Virtu KCG Holdings’s Achieve Life Sciences ACHV Stock Holding History

Virtu KCG Holdings’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$31K	Buy	39 +15	+63%	+$12.2K	﹤0.01%	2676
2017 Q1	$23K	Sell	24 -3	-11%	-$3.64K	﹤0.01%	2957
2016 Q4	$29K	Buy	+27	New	+$26.7K	﹤0.01%	3184
2016 Q3	–	Sell	-8	Closed	-$17K	–	3026
2016 Q2	$17K	Buy	+8	New	+$16.7K	﹤0.01%	2817
2016 Q1	–	Sell	-9	Closed	-$24K	–	2722
2015 Q4	$24K	Sell	9 -3	-25%	-$12.7K	﹤0.01%	3287
2015 Q3	$59K	Sell	12 -36	-75%	-$217K	﹤0.01%	2966
2015 Q2	$244K	Buy	48 +22	+85%	+$109K	﹤0.01%	2336
2015 Q1	$121K	Buy	26 +17	+189%	+$83.5K	﹤0.01%	2598
2014 Q4	$47K	Buy	9 +3	+50%	+$14.7K	﹤0.01%	3450
2014 Q3	$33K	Sell	6 -4	-40%	-$27.8K	﹤0.01%	3415
2014 Q2	$84K	Buy	+10	New	+$123K	﹤0.01%	3335

Other funds holding ACHV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Virtu KCG Holdings's ACHV Position: Q2 2017 in Review

Virtu KCG Holdings increased its Achieve Life Sciences (ACHV) stake by 63% in Q2 2017, buying an estimated $12.2K and bringing the position to 39 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

Virtu KCG Holdings first reported a position in ACHV in Q2 2014 and has held it in 11 quarters since. The position peaked at $244K in Q2 2015. 25 funds tracked by Wall St. Rank hold ACHV as of Q2 2017.

Virtu KCG Holdings held 39 shares of Achieve Life Sciences worth $31K as of Q2 2017.
Virtu KCG Holdings bought 15 Achieve Life Sciences shares in Q2 2017, an estimated $12.2K.
Achieve Life Sciences made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2676 holding.
Virtu KCG Holdings first reported a position in Achieve Life Sciences in Q2 2014 and has held it in 11 quarters since.
Virtu KCG Holdings's Achieve Life Sciences position peaked at $244K in Q2 2015.
25 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.